![Biomedicines | Free Full-Text | Open Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology Biomedicines | Free Full-Text | Open Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology](https://pub.mdpi-res.com/biomedicines/biomedicines-10-02679/article_deploy/html/images/biomedicines-10-02679-g001-550.jpg?1667556440)
Biomedicines | Free Full-Text | Open Source Repository and Online Calculator of Prediction Models for Diagnosis and Prognosis in Oncology
![Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma | Journal of Hematology & Oncology | Full Text Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01180-5/MediaObjects/13045_2021_1180_Fig1_HTML.png)
Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma | Journal of Hematology & Oncology | Full Text
![Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia](https://www.mdpi.com/cancers/cancers-15-02064/article_deploy/html/images/cancers-15-02064-g001.png)
Cancers | Free Full-Text | A Comparison between the Online Prognostic Tool PREDICT and myBeST for Women with Breast Cancer in Malaysia
A novel online calculator for estimating survival benefit of adjuvant TACE in patients undergoing surgery for HCC
![Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology](https://www.thelancet.com/cms/attachment/d9703228-fc3a-4361-8574-cece79e56c05/gr1.jpg)
Validity of Adjuvant! Online program in older patients with breast cancer: a population-based study - The Lancet Oncology
![The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients | British Journal of Cancer The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2016.359/MediaObjects/41416_2016_Article_BFbjc2016359_Fig1_HTML.jpg)
The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients | British Journal of Cancer
![Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence? - European Urology Open Science Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence? - European Urology Open Science](https://www.eu-openscience.europeanurology.com/cms/asset/a75447e0-cec6-4863-a212-917a9bae75dd/fx1.jpg)
Is Adjuvant Immunotherapy Worth for All Patients with Clear-cell Renal Cell Carcinoma at High Risk of Recurrence? - European Urology Open Science
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![PDF) An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning PDF) An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning](https://i1.rgstatic.net/publication/336287039_An_Online_Calculator_for_the_Prediction_of_Survival_in_Glioblastoma_Patients_Using_Classical_Statistics_and_Machine_Learning/links/5e6d0986a6fdccf994ca00c1/largepreview.png)
PDF) An Online Calculator for the Prediction of Survival in Glioblastoma Patients Using Classical Statistics and Machine Learning
![Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804912000986-gr2.jpg)
Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients - ScienceDirect
![A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library](https://acsjournals.onlinelibrary.wiley.com/cms/asset/b6de2dce-2a94-4150-ad30-2cf5c42d8be2/cncr34352-fig-0002-m.jpg)
A multi‐institutional prediction model to estimate the risk of recurrence and mortality after mastectomy for T1‐2N1 breast cancer - Sittenfeld - 2022 - Cancer - Wiley Online Library
![The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer The incidence of discordant clinical and genomic risk in patients with invasive lobular or ductal carcinoma of the breast: a National Cancer Database Study | npj Breast Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41523-021-00366-x/MediaObjects/41523_2021_366_Fig1_HTML.png)